MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
4.415
-0.235 (-5.05%)
Nov 7, 2025, 2:00 PM EST - Market open
MDxHealth Employees
MDxHealth had 312 employees as of December 31, 2024. The number of employees increased by 12 or 4.00% compared to the previous year.
Employees
312
Change (1Y)
12
Growth (1Y)
4.00%
Revenue / Employee
$317,157
Profits / Employee
-$110,933
Market Cap
218.53M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 312 | 12 | 4.00% |
| Dec 31, 2023 | 300 | 42 | 16.28% |
| Dec 31, 2022 | 258 | 67 | 35.08% |
| Dec 31, 2021 | 191 | 14 | 7.91% |
| Dec 31, 2020 | 177 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MDXH News
- 4 weeks ago - Angle PLC Announces Strategy Update - Accesswire
- 3 months ago - Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne - GlobeNewsWire
- 4 months ago - Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change - GlobeNewsWire
- 6 months ago - MDxHealth SA (MDXH) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - MDxHealth Reports Q1-2025 Results - GlobeNewsWire
- 9 months ago - MDxHealth SA (MDXH) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 9 months ago - Mdxhealth Announces Fourth Quarter and Full-Year 2024 Financial Results - GlobeNewsWire
- 10 months ago - MDxHealth Reports Preliminary Fourth Quarter and Full Year 2024 Revenues and Issues 2025 Revenue Guidance - GlobeNewsWire